Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $119.1 million.

  • Prestige Consumer Healthcare's Cash & Current Investments rose 131.09% to $119.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $407.4 million, marking a year-over-year increase of 107.97%. This contributed to the annual value of $97.9 million for FY2025, which is 110.64% up from last year.
  • Prestige Consumer Healthcare's Cash & Current Investments amounted to $119.1 million in Q3 2025, which was down 14.62% from $139.5 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Cash & Current Investments ranged from a high of $163.6 million in Q2 2021 and a low of $21.0 million during Q4 2021.
  • Moreover, its 3-year median value for Cash & Current Investments was $58.5 million (2023), whereas its average is $70.6 million.
  • Examining YoY changes over the last 5 years, Prestige Consumer Healthcare's Cash & Current Investments showed a top increase of 310.88% in 2022 and a maximum decrease of 78.08% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Cash & Current Investments (Quarterly) stood at $21.0 million in 2021, then surged by 310.88% to $86.4 million in 2022, then decreased by 26.34% to $63.6 million in 2023, then dropped by 20.03% to $50.9 million in 2024, then skyrocketed by 131.09% to $119.1 million in 2025.
  • Its last three reported values are $119.1 million in Q3 2025, $139.5 million for Q2 2025, and $97.9 million during Q1 2025.